News

Baseline diabetic retinopathy severity is an important predictor of its progression in patients.

The FDA has accepted Oyster Point Pharma's New Drug Application (NDA) for its OC-01 (varenicline) nasal spray to treat dry eye disease.

Autologous serum eye drops and blood products offer hope to patients.

Women 34% less likely to receive retinal detachment repair.

Check out the latest cartoon!

Tool can help physicians detect, monitor ophthalmic disease in their patients.

Visits, elective procedures decreased as physicians responded to COVID-19 guidelines.

Physicians step-up in emergency departments during COVID-19 surge.

With funding from the National Eye Institute, the team of researchers will focus on developing a broad-spectrum immunomodulatory eye drop for patients dealing with dry eye and ocular surface disease stemming from inflammatory and immune system disorders.

Investigators reviewing options that include bifocals, low-dose atropine drops

According to a survey by the Larry A. Green Center, in collaboration with the Primary Care Collaborative (PCC) and 3rd Conversation, primary care offers assets, including experience and relationships with patients.

Dealing with the COVID-19 virus affects everything to some degree, and investigators have found that mask wear can impact the accuracy of visual field tests.

Gene therapies to mitigate the effects of mutations that cause blindness are undergoing rapid development. Investigators have found that novel gene vectors reduce the risks associated with these procedures.

Treatment of patients with COVID-19 should include ophthalmic considerations.

Organization works to ensure clinical care and access for high-risk patients.

Dr. Bath could be the first African-American woman inducted into the Hall. As the first African-American woman to receive a medical patent, for the laserphaco probe, and the first woman to lead a post-graduate training program in ophthalmology, her experience is extensive.

The American Medical Association, American Hospital Association, American Nurses Association issued a sobering reality check as COVID-19 deaths in the United States passed the grim 500,000 milestone.

Findings from a new quality of life (QOL) assessment on thyroid eye disease (TED) indicate that the impact on patients extends well beyond its active phase and into the chronic phase.

Cataract surgeons must consider medication history as part of preoperative evaluation.

Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.

According to a study, ocular nodules have been found in the posterior pole and outside of the macular region in COVID-19 patients.

Studies look at absorption of drugs resulting in systemic complications.

The drop, formerly prescribed as Pazeo, joins Alcon’s over-the-counter ocular allergy portfolio to meet a variety of patient needs.

Growing patient pool is driving clinical trial investment.

Investigators find options could prove to be alternatives to surgical management.

Applicants must submit an original essay focusing on how biologics are transforming regenerative medicine in eye care. The deadline to apply is March 12.

Biophytis will begin recruiting patients in France and Belgium for the second part of the COVA Study analyzing its leading drug candidate as a potential treatment for acute respiratory failure linked to COVID-19.

Key is to recognize usual patterns for systemic and topical medications.